Viewing StudyNCT00458913



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00458913
Status: COMPLETED
Last Update Posted: 2018-07-12
First Post: 2007-04-09

Brief Title: Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Conditions & Keywords Data

Conditions:
Name
Malignant Mesothelioma
Keywords:
Name View
localized malignant mesothelioma View
recurrent malignant mesothelioma View
advanced malignant mesothelioma View